I thought they’re 20 billion below the expected revenue doesn’t say loss. Is this from another source?

“Patients often fell into a higher-cost billing category after a secondary diagnosis, a condition identified in addition to the patient’s primary reason for receiving care. This secondary diagnosis may be derived from single laboratory values, making it particularly well-suited for detection by AI tools. Approximately 70% of the additional costs, more than $650 million, were tied to secondary diagnoses.”

So if these are true positives they’re jist finding more stuff? How does that work with no treatment changes